Source: International Congress 2018 – Basic pharmacology
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
V. Russell (Verona, Italy), M. Brana (Verona, Italy), D. Pompilio (Verona, Italy), G. Ambrosi (Verona, Italy), F. Andreetta (Verona, Italy), E. Venturini (Verona, Italy), A. Chalidou (London, United Kingdom), M. Manni (Verona, Italy). Steroid-resistant inflammation in a mouse model of severe asthma is not inhibited by the combination of theophylline and budesonide. 1048

Member's Comments

No comment yet.

Related content which might interest you: Roflumilast but not dexamethasone or fluticasone reduces neutrophilic airway inflammation and hyperreactivity in a murine influenza-induced asthma exacerbation model Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016 Effect of oral prednisolone on the bronchoprotective effect of formoterol in patients with persistent asthma Source: Eur Respir J 2001; 17: 374-379 Year: 2001 Salmeterol treatment improves corticosteroid responsivness in patients with corticosteroid-insensitive severe asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Corticosteroid sensitivity in patients with chronic obstructive pulmonary disease is restored by theophylline Source: Annual Congress 2005 - Therapeutic options for COPD: present and future Year: 2005 Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004 Comparison of anti-inflammatory and clinical effects of beclomethasone dipropionate and salmeterol in moderate asthma Source: Eur Respir J 2002; 20: 66-72 Year: 2002 Treatment with inhaled steroids in patients with symptoms suggestive of asthma but with normal lung function Source: Eur Respir J 2008; 32: 989-996 Year: 2008 The new approaches to the oral corticosteroid dosage decrease in patients with severe steroid-resistant bronchial asthma Source: Annual Congress 2005 - Improving asthma control in the harder-to-reach population Year: 2005 Formoterol restores corticosteroid responses in corticosteroid-insensitive severe asthma Source: Eur Respir J 2005; 26: Suppl. 49, 50s Year: 2005 Inhaled PPAR-r agonist inhibit the airway inflammation in murine model of acute and chronic asthma Source: Eur Respir J 2007; 30: Suppl. 51, 24s Year: 2007 Nebulizer therapy with budesonide in addition to systemic corticosteroids in acute severe asthma Source: Eur Respir J 2004; 24: Suppl. 48, 541s Year: 2004 Inhaled budesonide suppresses airway and systemic eosinophilic inflammation in COPD. No predictive value of a prednisolone test treatment Source: Eur Respir J 2005; 26: Suppl. 49, 290s Year: 2005 MIF antagonism restores corticosteroid sensitivity in a murine model of severe asthma Source: International Congress 2018 – Identification of therapeutic targets for asthma Year: 2018 Effects of budesonide/formoterol maintenance therapy on airway hyperresponsiveness and inflammation in an allergic rat model Source: Eur Respir J 2004; 24: Suppl. 48, 351s Year: 2004 Long-acting anticholinergic, aclidinium bromide (AB) significantly attenuates airway inflammation and hyper-responsiveness in an AF-induced murine model of asthma Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009 Effect of budesonide/formoterol combination on an airway hyperresponsiveness and inflammation model in mice Source: Eur Respir J 2004; 24: Suppl. 48, 131s Year: 2004 Effects of corticosteroid and montelukast treatment in inflammation in guinea pigs with chronic allergic inflammation Source: Annual Congress 2012 - Animal models of asthma and COPD and late-breaking abstracts on RCT in asthma and COPD Year: 2012 Use of budesonide suspension during the exacerbation of severe steroid-dependent bronchial asthma Source: Eur Respir J 2001; 18: Suppl. 33, 47s Year: 2001 Budesonide and formoterol in a single inhaler controls exacerbations more effectively than a higher dose of inhaled corticosteroids alone, in mild-moderate persistent asthma Source: Eur Respir J 2001; 18: Suppl. 33, 43s Year: 2001 Mepolizumab and the response to oral prednisolone in patients with severe eosinophilic asthma Source: International Congress 2017 – Asthma management Year: 2017